Description: Austar Lifesciences Limited, an investment holding company, provides integrated engineering solutions to pharmaceutical manufacturers and research institutes in Mainland China and internationally. It operates through six segments: Liquid and Bioprocess System; Clean Room and Automation Control and Monitoring System; Powder and Solid System; GMP Compliance Service; Life Science Consumables; and Distribution and Agency of Pharmaceutical Equipment. The company offers liquid and bioprocess systems, including pharmaceutical water, and liquid preparation and bioprocess systems; powder and solid systems; clean utility equipment and systems; clean room, automation control, and monitor systems; and freeze-dryer, sterile filling, and visual inspection equipment. It also provides pharmaceutical process contamination control products; packaging and aseptic containment products; biosafety and lab animal equipment and consumables; laboratory one-stop solutions; and single-use bioprocess equipment and consumables. In addition, the company offers design, quality risk control, consulting, research and development support, process engineering, digitalization construction, after-sale, on-site, upgrading, relocation, and asset management services. Further, it is involved in the agency and distribution of pharmaceutical equipment, as well as provides assembly and pre-assembly services. The company was founded in 1991 and is headquartered in Shanghai, China.
Home Page: www.austar.com.hk
Rooms 2010-2013
Shanghai,
China
Phone:
86 40 0812 1586
Officers
Name | Title |
---|---|
Mr. Kwok Keung Ho | Founder, Chairman & CEO |
Mr. Yuewu Chen | Exec. Director |
Madam Ning Zhou | Exec. Director |
Mr. Kin Hung Ho | Exec. Director |
Madam Xiangdi Tang | VP of Corp. Devel. |
Ms. Yuk Kiu Mak | Company Sec. |
Exchange: HK
Country: HK : Hong Kong
Currency: Hong Kong Dollar (HK$)
GIC Sector: | Health Care |
---|---|
GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
GIC Industry: | Life Sciences Tools & Services |
GIC Sub-Industry: | Life Sciences Tools & Services |
Forward PE: | 0 |
---|---|
Trailing PE: | 8.5909 |
Price-to-Book MRQ: | 1.3134 |
Price-to-Sales TTM: | 0.4936 |
IPO Date: | |
Fiscal Year End: | December |
Full Time Employees: | 1785 |